None
Quote | Bioxytran Inc (OTCMKTS:BIXT)
Last: | $0.087 |
---|---|
Change Percent: | -6.52% |
Open: | $0.098 |
Close: | $0.087 |
High: | $0.098 |
Low: | $0.087 |
Volume: | 1,006 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Bioxytran Inc (OTCMKTS:BIXT)
BXT-25 is expected to oxygenate the brain BOSTON, MASSACHUSETTS, June 27, 2024 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing drugs to treat stroke and Alzheimer's disease, announced that Bioxtran’s...
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
Message Board Posts | Bioxytran Inc (OTCMKTS:BIXT)
Subject | By | Source | When |
---|---|---|---|
$BIXT's recent performance is characterized by a remarkable 6.24% increase in its trading price, rea | 10/27/2023 3:21:27 PM | ||
The USPTO's publication of $BIXT's patent signifies its commitment to advancing healthcare. Reflecti | 10/27/2023 1:36:47 PM | ||
Explore $BIXT's dedication to healthcare transformation. Their mission is clear: develop and commerc | 10/27/2023 8:01:05 AM | ||
Bioxytran, Inc. ( $BIXT) on their journey to improve healthcare. Their 144 million outstanding share | 10/26/2023 1:31:16 PM | ||
Bioxytran, Inc. ($BIXT) is making waves in antiviral research. Their patent application signals sign | 10/26/2023 10:52:34 AM |
News, Short Squeeze, Breakout and More Instantly...
BXT-25 is expected to oxygenate the brain BOSTON, MASSACHUSETTS, June 27, 2024 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing drugs to treat stroke and Alzheimer's disease, announced that Bioxtran’s...
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
AIA Group Limited ADR (AAGIY) is expected to report for Q4 2023 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 SecureWorks Corp. (SCWX) is expected to report $-0.15 for Q4 2024 Acacia Research Corporation (ACTG) is expected to report for quarter end...